Sharma et al present the prospective comprehensive analysis of 60 patients with NSCLC: "Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non–Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy​". Each patient underwent dynamic sequential whole-body 18F-FDG with quantitative perfusion PET tumor analysis. Authors concluded that baseline MTV and TLG of primary tumor or whole-body tumor lesions are reliable prognostic markers of OS in NSCLC patients undergoing platinum-based chemotherapy. However, other SUVmax, average SUV, tumor-to-background ratio and dynamic PET/CT parameters have no prognostic value in this cohort.​

Current Issue


223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice

van der Doelen, Maarten J.; Kuppen, Malou C.P.; Jonker, Marianne A.; More

Clinical Nuclear Medicine. 43(1):9-16, January 2018.

Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non–Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy

Sharma, Akshima; Mohan, Anant; Bhalla, Ashu Seith; More

Clinical Nuclear Medicine. 43(1):e8-e17, January 2018.




1 2 3 4 5